Latest Big Rounds Herald A China Biotech Funding Spring?

Around the turn of the year, four Chinese biotechs including Kelun Biotech and BioRay ramped up funding with deals worth more than $100m, at a time when overall investment sentiment in the sector remains gloomy.

deal spike
spike in large VC/PE deals involving Chinese biotechs at the turn of the year • Source: Shutterstock

The turn of the year witnessed a spike in venture capital and private equity funding deals in China, with several valued at around the $100m level.

A string of four large financings around late December struck a high note, in stark contrast to the generally dampened...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Focus On Asia